Massachusetts Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-112,240
| Closed | -$21.5M | – | 838 |
|
|
2023
Q4 | $21.5M | Sell |
112,240
-575,988
| -84% | -$110M | 0.01% | 560 |
|
|
2023
Q3 | $122M | Buy |
688,228
+15,831
| +2% | +$2.8M | 0.04% | 332 |
|
|
2023
Q2 | $128M | Sell |
672,397
-93,375
| -12% | -$17.7M | 0.04% | 327 |
|
|
2023
Q1 | $153M | Buy |
765,772
+10,230
| +1% | +$2.05M | 0.05% | 281 |
|
|
2022
Q4 | $180M | Buy |
755,542
+219,943
| +41% | +$52.3M | 0.06% | 252 |
|
|
2022
Q3 | $107M | Buy |
535,599
+191,310
| +56% | +$38.3M | 0.04% | 327 |
|
|
2022
Q2 | $50.2M | Buy |
344,289
+41,546
| +14% | +$6.06M | 0.02% | 453 |
|
|
2022
Q1 | $49.4M | Sell |
302,743
-1,019,468
| -77% | -$166M | 0.01% | 483 |
|
|
2021
Q4 | $224M | Sell |
1,322,211
-43,076
| -3% | -$7.3M | 0.06% | 259 |
|
|
2021
Q3 | $258M | Sell |
1,365,287
-9,856
| -0.7% | -$1.86M | 0.08% | 223 |
|
|
2021
Q2 | $233M | Sell |
1,375,143
-86,919
| -6% | -$14.7M | 0.07% | 240 |
|
|
2021
Q1 | $206M | Sell |
1,462,062
-301,305
| -17% | -$42.5M | 0.06% | 254 |
|
|
2020
Q4 | $229M | Sell |
1,763,367
-142,023
| -7% | -$18.5M | 0.07% | 227 |
|
|
2020
Q3 | $277M | Buy |
1,905,390
+842,211
| +79% | +$123M | 0.1% | 192 |
|
|
2020
Q2 | $157M | Buy |
+1,063,179
| New | +$157M | 0.06% | 243 |
|
|
2016
Q4 | – | Sell |
-78,048
| Closed | -$5.29M | – | 849 |
|
|
2016
Q3 | $5.29M | Buy |
78,048
+767
| +1% | +$52K | ﹤0.01% | 640 |
|
|
2016
Q2 | $4.29M | Sell |
77,281
-2,697
| -3% | -$150K | ﹤0.01% | 655 |
|
|
2016
Q1 | $5.02M | Buy |
79,978
+985
| +1% | +$61.8K | ﹤0.01% | 640 |
|
|
2015
Q4 | $7.44M | Sell |
78,993
-537
| -0.7% | -$50.6K | ﹤0.01% | 612 |
|
|
2015
Q3 | $6.39M | Sell |
79,530
-1,472
| -2% | -$118K | ﹤0.01% | 641 |
|
|
2015
Q2 | $9.71M | Sell |
81,002
-1,268
| -2% | -$152K | ﹤0.01% | 615 |
|
|
2015
Q1 | $8.59M | Buy |
82,270
+2,548
| +3% | +$266K | ﹤0.01% | 626 |
|
|
2014
Q4 | $7.73M | Buy |
+79,722
| New | +$7.73M | ﹤0.01% | 637 |
|